Furthermore, Chan et al. reported that SOX7 was significantly downregulated in high grade endometrial cancer, and overexpression of SOX7 reduced endometrial cancer cell growth via suppression of Wnt/β-catenin signaling [21]. Here, SOX7 is linked to endometrial cancer.